More information: Jan C. Klapwijk et al, Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

Whether or not to cover these procedures, and if so, coverage details, should be decided on before their popularity grows.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

Initiation of Phase 1b study using SGT-212 for the treatment of patients with Friedreich's Ataxia expected in 2H25. Click ...